PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells.
E Glodkowska-MrowkaA Manda-HandzlikA Stelmaszczyk-EmmelI SeferynskaT StoklosaJ PrzybylskiPiotr MrówkaPublished in: Blood cancer journal (2016)